
IOL Chemicals Submits BRSR Report for FY 2025-26
IOL Chemicals & Pharmaceuticals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which forms an integral part of the company's Integrated Annual Report, details the company's performance across environmental, social, and governance (ESG) parameters. Key disclosures include business activities contributing to turnover (Pharma Segment 60%, Chemical Segment 40%), products sold (APIs and Intermediates 59.66%, Specialty Chemicals 39.43%), employee details (3592 total employees), and market reach (23 national states, 70 international countries). The BRSR was prepared on a standalone basis and received reasonable assurance from Intertek India Private Limited.
Key Highlights
- Company submitted BRSR for FY 2025-26.
- Report covers ESG performance and disclosures.
- Pharma and Chemical segments are key business areas.
- Active Pharma Ingredients and Specialty Chemicals are major products.
- Report is based on standalone financial data.
Price Impact
More from IOLCP